This article by Marija Martini summarizes important studies on the programmed cell death-1 receptor (PD-1) glycosylation and its influence on immunotherapeutics discovery, using new features from the 3decision V2.0 release.
Understanding glycan-sensitive vs glycan-agnostic PD-1 antibodies using 3decision 2.0
Previous
Previous
Discngine at Future Labs Live 2025 in Basel, Switzerland
Next
Next